王涛;晋红中;

• 1:中国医学科学院 北京协和医学院 北京协和医院皮肤科

摘要(Abstract)：

<正>红皮病性银屑病(erythrodermic psoriasis,EDP)是银屑病中病情较为严重的一种,又称为银屑病性剥脱性皮炎。既往报道EDP约占银屑病患者的1.5%～2.25%不等,银屑病导致的红皮病占所有红皮病的25%[1]。但本病的实际发病率在国内可能会更高。EDP多见于成人,儿童较少见[2]。临床上,常将炎症性皮损面积超过体表面积的90%,伴或不伴有脱屑,均称为EDP,也因此称银屑病性红皮病。EDP需要与其他红皮病类疾病,如毛发红糠疹、皮炎湿疹所致红皮病(尤其是重症异位性皮炎)、系统性或泛发型药疹、淋巴瘤所致的红皮病(如Sèzary综合征)等鉴别。本病常由系统使用糖皮质激

关键词(KeyWords)： 红皮病性银屑病;治疗

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 王涛;晋红中;

Email:

DOI:

参考文献(References)：

• [1]Rosenbach M,Hsu S,Korman NJ,et al.Treatment of eryth-rodermic psoriasis:from the medical board of the National Psoriasis Foundation[J].J Am Acad Dermatol,2010,62:655-662.
• [2]Yuan XY,Guo JY,Dang YP,et al.Erythroderma:A clini-cal-etiological study of82cases[J].Eur J Dermatol,2010,20:373-377.
• [3]Shekelle PG,Woolf SH,Eccles M,et al.Clinical guide-lines:developing guidelines[J].BMJ,1999,318:593-596.
• [4]Maza A,Montaudie H,Sbidian E,et al.Oral cyclosporin in psoriasis:a systematic review on treatment modalities,risk of kidney toxicity and evidence for use in non-plaque psoriasis[J].J Eur Acad Dermatol Venereol,2011,25Suppl2:19-27.
• [5]Poulalhon N,Begon E,Lebbe C,et al.A follow-up study in28patients treated with infliximab for severe recalcitrant psori-asis:evidence for efficacy and high incidence of biological au-toimmunity[J].Br J Dermatol,2007,156:329-336.
• [6]Paul C,Gallini A,Maza A,et al.Evidence-based recom-mendations on conventional systemic treatments in psoriasis:systematic review and expert opinion of a panel of dermatolo-gists[J].J Eur Acad Dermatol Venereol,2011,25Suppl2:2-11.
• [7]Esposito M,Mazzotta A,de Felice C,et al.Treatment of erythrodermic psoriasis with etanercept[J].Br J Dermatol,2006,155:156-159.
• [8]Takahashi MD,Castro LG,Romiti R.Infliximab,as sole or combined therapy,induces rapid clearing of erythrodermic psoriasis[J].Br J Dermatol,2007,157:828-831.
• [9]Heikkila H,Ranki A,Cajanus S,et al.Infliximab com-bined with methotrexate as long-term treatment for erythro-dermic psoriasis[J].Arch Dermatol,2005,141:1607-1610.
• [10]Brechtel B,Wellenreuther U,Toppe E,et al.Combination of etretinate with cyclosporine in the treatment of severe re-calcitrant psoriasis[J].J Am Acad Dermatol,1994,30:1023-1024.
• [11]Clark CM,Kirby B,Morris AD,et al.Combination treat-ment with methotrexate and cyclosporin for severe recalcitrant psoriasis[J].Br J Dermatol,1999,141:279-282.
• [12]Prossick TA,Belsito DV.Alefacept in the treatment of re-calcitrant palmoplantar and erythrodermic psoriasis[J].Cutis,2006,78:178-180.
• [13]Rongioletti F,Borenstein M,Kirsner R,et al.Erythroder-mic,recalcitrant psoriasis:clinical resolution with infliximab[J].J Dermatolog Treat,2003,14:222-225.
• [14]Viguier M,Pagès C,Aubin F,et al.Efficacy and safety of biologics in erythrodermic psoriasis:a multicentre,retro-spective study[J].Br J Dermatol,2012,167:417-423.
• [15]Kelsen J,Dige A,Schwindt H,et al.Infliximab induces clonal expansion of gammadelta-T cells in Crohn's disease:a predictor of lymphoma risk[J].PLoS One,2011,6:e17890.
• [16]Alcain G,Andrade RJ,de Llano MP Q,et al.Acute leuke-mia after infliximab therapy[J].Am J Gastroenterol,2003,98:2577.
• [17]Dauendorffer JN,Rivet J,Allard A,et al.Sezary syndrome in a patient receiving infliximab for ankylosing spondylitis[J].Br J Dermatol,2007,156:742-743.
• [18]Sanli H,Ataman S,Akay BN,et al.Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy[J].J Drugs Dermatol,2007,6:834-836.
• [19]Parakkal D,Sifuentes H,Semer R,et al.Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor ther-apy:expanding the groups at risk[J].Eur J Gastroenterol Hepatol,2011,23:1150-1156.
• [20]Pietrzak A,Chodorowska G,Jazienicka I,et al.Psoriatic erythroderma coexisting with erythema multiforme-like lesions induced by retinoids or retinoids combined with an antibiotic:case report[J].Dermatol Ther,2011,24:587-590.
• [21]Richetta AG,Maiani E,Carlomagno V,et al.Treatment of erythrodermic psoriasis in HCV+patient with adalimumab[J].Dermatol Ther,2009,22Suppl1:S16-S18.
• [22]Mahe E,Descamps V,Grossin M,et al.CD30+T-cell lym-phoma in a patient with psoriasis treated with ciclosporin and infliximab[J].Br J Dermatol,2003,149:170-173.
• [23]Corazza M,Zampino MR,Montanari A,et al.Primary cuta-neous CD30+large T-cell lymphoma in a patient with psoria-sis treated with cyclosporine[J].Dermatology,2003,206:330-333.
• [24]Kuijpers AL,van Dooren-Greebe JV,van de Kerkhof PC.Failure of combination therapy with acitretin and cyclosporin A in3patients with erythrodermic psoriasis[J].Dermatolo-gy,1997,194:88-90.
• [25]Roeder C,Driesch PV.Psoriatic erythroderma and bullous pemphigoid treated successfully with acitretin and azathio-prine[J].Eur J Dermatol,1999,9:537-539.
• [26]何玉清,张锡宝,曾抗,等.阿维A与甲氨蝶呤治疗泛发性脓疱型和红皮病型银屑病的疗效及安全性评价[J].岭南皮肤性病科杂志,2006,(1):13-16.
• [27]王冬云,刘平,彭振辉.窄谱UVB联合阿维A酸治疗红皮病型银屑病[J].实用医学杂志,2005,(13):1453-1454.